SEC 13F Intelligence

Carlson Capital, L.P. / IMMU

Carlson Capital, L.P.’s Immunomedics Inc Position

Does Carlson Capital, L.P. own Immunomedics Inc (IMMU)? Not currently — the last reported position was 1.55M shares worth $132M in Q3 2020; the fund’s latest 13F (Q1 2026) no longer reports it.

Position Value
$132M
Q3 2020
Shares
1.55M
% of Portfolio
+1.93%
Quarters Held
1
position exited

Position History IMMU

Reported value by quarter
Q3 ’20: $132MQ3 ’20filingsflow.com
QuarterSharesValue% of Portfolio
Q3 20201.55M$132M+1.93%

Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Carlson Capital, L.P.’s full portfolio or all institutional holders of IMMU.